ISSN: 2456-3102
E Robert Wassman
Chromosomal microarray (CMA) is a standard first-tier diagnostic for autism spectrum disorders (ASD) and other neurodevelopmental conditions and is now complemented by whole exome sequencing (WES) to identify potentially pathogenic variants in over half of such cases today.